On Mar. 24, 2020, BioSig Technologies announced that its majority-owned subsidiary NeuroClear Technologies, acquired the rights to develop a…
On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…
On Mar. 24, 2020, Windtree Therapeutics announced it will study its proprietary KL4 surfactant to potentially mitigate the…
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
On Mar. 24, 2020, Partner Therapeutics that Leukine (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim…
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
On Mar. 24, 2020, to help in educating the public and in the hope of better conveying the…
On Mar. 24, 2020, the University of Alberta (U of A) announced that a Public health study was…
On Mar. 24, 2020, 3M and Ford Motor Co. announced that they had entered into a partnership in…
On Mar. 24, 2020, Bausch Health announced it had donated medicines and health care products to assist in…
On Mar. 24, 2020, an international project aimed to enroll 500 COVID-19 patients to search for genetic mutations…
On Mar. 24, 2020, three Oxford University-based COVID-19 projects were among the first to benefit from a share…
On Mar. 24, 2020, Dynavax Technologies and Clover Biopharmaceuticals, a China-based global clinical-stage biotechnology company, announced a research…
On Mar. 24, 2020, aTyr Pharma announced announced that the companyﾒs Hong Kong subsidiary, Pangu BioPharma, together with…
On Mar. 23, 2020, Harvard Bioscience announced that it had launched an innovative technology – known as Accumulated…
On Mar. 23, 2020, Covetrus reported that the company saw strong demand in its prescription management and online…
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
On Mar. 23, 2020, an expert team of researchers and clinicians in microbiology, virology, pathology, molecular science, and…
On Mar. 23, 2020, Resverlogix announced a bioRxiv publication that has shown apabetalone to inhibit specialized proteins –…
On Mar. 23, 2020, Resverlogix announced that it was seeking to collaborate with organizations currently testing therapies for…
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
On Mar. 23, 2020, researchers from the University of Oxford announced they have launched a new clinical trial…
On Mar. 23, 2020, the UK Government announced funding of £20 million to support clinicians and scientists in…
On Mar. 23, 2020, the Amgen Foundation announced an initial commitment of up to $12.5 million to support…
On Mar. 23, 2020, Cumberland Pharmaceuticals announced a national initiative to support the treatment of patients with hospital-acquired and…
On Mar. 23, 2020, Drug Innovation Ventures at Emory (DRIVE), and Ridgeback Biotherapeutics announced a collaboration to rapidly…
On Mar. 23, 2020, Acura Pharmaceuticals announced that Abuse Deterrent Pharma, its licensee of LTX-03 (Hydrocodone Bitartrate and…
On Mar. 22, 2020, Royal Philips announced that it is increasing the production of certain critical care products and…
On Mar. 20, 2020, Amneal Pharmaceuticals, one of the largest U.S.-based generics manufacturers, announced that it is responding to…